X4 Pharmaceuticals, Inc. (XFOR)
NASDAQ: XFOR · Real-Time Price · USD
4.070
-0.050 (-1.21%)
Apr 29, 2026, 1:19 PM EDT - Market open
X4 Pharmaceuticals Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Cash & Equivalents | 217.05 | 55.7 | 99.22 | 121.72 | 81.79 | Upgrade
|
| Short-Term Investments | 35.95 | 46.36 | 15 | - | - | Upgrade
|
| Cash & Short-Term Investments | 253 | 102.06 | 114.22 | 121.72 | 81.79 | Upgrade
|
| Cash Growth | 147.89% | -10.64% | -6.16% | 48.82% | 3.91% | Upgrade
|
| Accounts Receivable | 0.57 | 1.07 | - | - | - | Upgrade
|
| Other Receivables | - | 0.64 | 0.56 | 1.15 | 0.75 | Upgrade
|
| Receivables | 0.57 | 1.71 | 0.56 | 1.15 | 0.75 | Upgrade
|
| Inventory | 4.48 | 2.82 | - | - | - | Upgrade
|
| Prepaid Expenses | 2.52 | 5.59 | 7.05 | 5.52 | 5.34 | Upgrade
|
| Restricted Cash | 0.8 | - | 0.25 | 0.29 | - | Upgrade
|
| Other Current Assets | 0.2 | - | - | - | - | Upgrade
|
| Total Current Assets | 261.58 | 112.18 | 122.08 | 128.68 | 87.88 | Upgrade
|
| Property, Plant & Equipment | 1.59 | 4.84 | 6.4 | 8.33 | 10.22 | Upgrade
|
| Goodwill | 17.35 | 17.35 | 17.35 | 17.35 | 17.35 | Upgrade
|
| Other Intangible Assets | 9.25 | 10 | - | - | - | Upgrade
|
| Long-Term Deferred Charges | 0.5 | - | - | - | - | Upgrade
|
| Other Long-Term Assets | 0.19 | 2.08 | 1.44 | 1.23 | 1.72 | Upgrade
|
| Total Assets | 290.46 | 146.45 | 147.26 | 155.59 | 117.18 | Upgrade
|
| Accounts Payable | 5.7 | 8.62 | 8.95 | 7.78 | 4.28 | Upgrade
|
| Accrued Expenses | 18.6 | 23.01 | 12.82 | 11.44 | 7.85 | Upgrade
|
| Current Portion of Long-Term Debt | - | - | - | 1.32 | 0.8 | Upgrade
|
| Current Portion of Leases | 0.99 | 1.25 | 1.1 | 1.2 | 1.08 | Upgrade
|
| Current Unearned Revenue | 0.46 | - | - | - | - | Upgrade
|
| Other Current Liabilities | - | - | - | 0.59 | 0.03 | Upgrade
|
| Total Current Liabilities | 25.76 | 32.88 | 22.86 | 22.32 | 14.02 | Upgrade
|
| Long-Term Debt | 76.29 | 75.43 | 54.57 | 32.3 | 33.14 | Upgrade
|
| Long-Term Leases | - | 1.41 | 2.61 | 3.6 | 4.78 | Upgrade
|
| Long-Term Unearned Revenue | 0.62 | - | - | - | - | Upgrade
|
| Other Long-Term Liabilities | 1.5 | 14.59 | 16.12 | 23.3 | 0.83 | Upgrade
|
| Total Liabilities | 104.17 | 124.3 | 96.16 | 81.54 | 52.76 | Upgrade
|
| Common Stock | 0.09 | 0.01 | 0.17 | 0.12 | 0.03 | Upgrade
|
| Additional Paid-In Capital | 780.86 | 537.62 | 528.96 | 450.79 | 347.37 | Upgrade
|
| Retained Earnings | -594.55 | -515.36 | -477.91 | -376.74 | -282.87 | Upgrade
|
| Comprehensive Income & Other | -0.11 | -0.12 | -0.12 | -0.12 | -0.12 | Upgrade
|
| Total Common Equity | 186.29 | 22.15 | 51.1 | 74.05 | 64.41 | Upgrade
|
| Shareholders' Equity | 186.29 | 22.15 | 51.1 | 74.05 | 64.41 | Upgrade
|
| Total Liabilities & Equity | 290.46 | 146.45 | 147.26 | 155.59 | 117.18 | Upgrade
|
| Total Debt | 77.29 | 78.09 | 58.28 | 38.42 | 39.79 | Upgrade
|
| Net Cash (Debt) | 175.71 | 23.97 | 55.94 | 83.3 | 42 | Upgrade
|
| Net Cash Growth | 632.93% | -57.14% | -32.85% | 98.32% | 4.33% | Upgrade
|
| Net Cash Per Share | 4.15 | 3.58 | 9.44 | 39.34 | 48.94 | Upgrade
|
| Filing Date Shares Outstanding | 90.92 | 5.79 | 5.6 | 4.07 | 1.03 | Upgrade
|
| Total Common Shares Outstanding | 90.91 | 5.7 | 5.58 | 4.06 | 0.94 | Upgrade
|
| Working Capital | 235.82 | 79.3 | 99.21 | 106.35 | 73.86 | Upgrade
|
| Book Value Per Share | 2.05 | 3.89 | 9.16 | 18.26 | 68.70 | Upgrade
|
| Tangible Book Value | 159.69 | -5.2 | 33.75 | 56.7 | 47.06 | Upgrade
|
| Tangible Book Value Per Share | 1.76 | -0.91 | 6.05 | 13.98 | 50.19 | Upgrade
|
| Machinery | 1.19 | 2.43 | 2.11 | 2.08 | 1.98 | Upgrade
|
| Leasehold Improvements | 0.23 | 0.23 | 0.23 | 0.23 | 0.23 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.